| Company
| Exchange
| Symbol
| Last price
|
| Quote change
| Market cap
|
|
|
Roche Holding Ltd.
| VTX
|
ROG
|
|
|
|
|
|
|
Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It
belongs to the Roche Group that operates through subsidiaries and associated ...
| |
| |
|
|
Roche Holding Ltd. (ADR)
| OTCMKTS
|
RHHBY
|
65.96
|
|
+0.40
(0.61%)
| 227.58B
|
|
|
Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It
belongs to the Roche Group that operates through subsidiaries and associated ...
| |
| |
|
|
PDL BioPharma Inc.
| NASDAQ
|
PDLI
|
8.37
|
|
+0.02
(0.24%)
| 1.17B
|
|
|
PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the
management of antibody humanization patents and royalty assets, which consist of
...
| |
| |
|
|
ROCHE HLDG AG DIV RT
| OTCMKTS
|
RHHVF
|
262.26
|
|
-0.24
(-0.09%)
| 184.42B
|
|
|
|
|
|
Genentech, Inc.
| Private
|
|
|
|
|
|
|
|
... human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma
drug Xolair. Genentech is wholly owned by Swiss drugmaker Roche.
| |
| |
|
|
ROCHE HLDGS AG BEARE
| OTCMKTS
|
RHHBF
|
264.00
|
|
+2.00
(0.76%)
| 41.92B
|
|
|
|
|
|
ROCHE HLDG AG INH. SF 1
| ETR
|
RHO
|
202.85
|
|
+3.35
(1.68%)
|
|
|
|
|
|
|
Roche Holding AG
| FRA
|
RHO5
|
|
|
|
|
|
|
Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It
belongs to the Roche Group that operates through subsidiaries and associated ...
| |
| |
|
|
ROCHE HLDG AG INH. SF 1
| FRA
|
RHO
|
202.58
|
|
+1.14
(0.57%)
|
|
|
|
|
|
|
Seattle Genetics, Inc.
| NASDAQ
|
SGEN
|
34.95
|
|
-0.40
(-1.13%)
| 4.24B
|
|
|
Seattle Genetics, Inc. is biotechnology company focused on the development and
commercialization of monoclonal antibody-based therapies for cancer.
| |
| |
|
|
Roche Holding Ltd. (Bearer Share)
| SWX
|
RO
|
|
|
|
|
|
|
Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It
belongs to the Roche Group that operates through subsidiaries and associated ...
| |
| |
|
|
PDL BIOPHARMA INC. DL-,01
| FRA
|
PDL
|
6.41
|
|
0.00
(-0.03%)
|
|
|
|
|
|
|
Astellas Pharma Inc
| TYO
|
4503
|
5,410.00
|
|
-70.00
(-1.28%)
| 2.44T
|
|
|
Astellas Pharma Inc. is a Japan-based company mainly engaged in the
pharmaceutical business. The Company is involved in the manufacture and sale of
...
| |
| |
|
|
SEATTLE GENETICS DL-,001
| FRA
|
SGT
|
26.77
|
|
+0.53
(2.04%)
|
|
|
|
|
|
|
ImmunoGen, Inc.
| NASDAQ
|
IMGN
|
17.89
|
|
+0.15
(0.85%)
| 1.51B
|
|
|
ImmunoGen, Inc. (ImmunoGen) develops targeted, antibody-based therapeutics for
the treatment of cancer. ImmunoGen designs linkers that enable antibody-based
...
| |
| |
|
|
ASTELLAS PHARMA INC
| OTCMKTS
|
ALPMF
|
51.57
|
|
-1.58
(-2.97%)
| 24.87B
|
|
|
|
|
|
ASTELLAS PHARMA INC
| OTCMKTS
|
ALPMY
|
13.15
|
|
-0.37
(-2.74%)
| 25.31B
|
|
|
|
|
|
ASTELLAS PHARMA INC.
| FRA
|
YPH
|
40.60
|
|
-2.06
(-4.82%)
|
|
|
|
|
|
|
IMMUNOGEN INC. DL-,01
| FRA
|
IMU
|
13.90
|
|
+0.76
(5.78%)
|
|
|
|
|
|
